MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

NCT00618917 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped MnSOD longer available during Phase II

Conditions

Esophageal
Toxicity

Interventions

GENETIC: Manganese Superoxide Dismutase Plasmid Liposome
DRUG: carboplatin
DRUG: paclitaxel
RADIATION: Radiation Therapy

Sponsor

Joel Greenberger